연구성과로 돌아가기
JCR 2022 저널 목록 (429 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE | SPRINGER | 1073-5623 | 1543-1940 | SCIE | METALLURGY & METALLURGICAL ENGINEERING | 36,285 | 2.8 | Q2 | 31.0 | 69.0 | 25/79 | 2.8 | Q2 | 2.6 | 0.5 | 0.56 | 26/91 | Q2 | 71.98 | 0.012 | 2.556 | 0.498 | Q2 | 383 | 99.7% | 13.8 | 9.4 | 382 | 18.1% | 2025-04-21 10:16:42 | 바로가기 |
| Nanotechnology Reviews | DE GRUYTER POLAND SP Z O O | 2191-9089 | 2191-9097 | SCIE | NANOSCIENCE & NANOTECHNOLOGY | 3,937 | 7.4 | Q2 | 31.0 | 69.0 | 34/108 | 7.2 | Q2 | 6.4 | 3.0 | 0.78 | 52/141 | Q2 | 63.48 | 0.003 | 0.652 | 0.890 | Q2 | 188 | 67.0% | 2.6 | 5.2 | 126 | 96.5% | 2025-04-21 10:18:29 | 바로가기 |
| PROCEEDINGS OF THE COMBUSTION INSTITUTE | ELSEVIER SCIENCE INC | 1540-7489 | 1873-2704 | SCIE | THERMODYNAMICS | 16,383 | 3.4 | Q2 | 31.0 | 69.0 | 20/63 | 3.8 | Q1 | 3.4 | N/A | 0.95 | 16/78 | Q1 | 80.13 | 0.014 | 3.153 | 0.896 | Q1 | 0 | N/A | 7.7 | N/A | 0 | 29.7% | 2025-04-21 10:39:18 | 바로가기 |
| SOFTWARE-PRACTICE & EXPERIENCE | WILEY | 0038-0644 | 1097-024X | SCIE | COMPUTER SCIENCE, SOFTWARE ENGINEERING | 3,263 | 3.5 | Q2 | 31.0 | 69.0 | 34/108 | 3.0 | Q2 | 3.2 | 0.8 | 0.87 | 38/132 | Q2 | 71.59 | 0.002 | 0.489 | 0.456 | Q3 | 104 | 94.2% | 5.5 | 5.8 | 98 | 9.6% | 2025-04-21 09:42:33 | 바로가기 |
| TRANSFUSION MEDICINE REVIEWS | W B SAUNDERS CO-ELSEVIER INC | 0887-7963 | 1532-9496 | SCIE | HEMATOLOGY | 1,658 | 4.5 | Q2 | 31.0 | 69.0 | 25/79 | 4.1 | Q2 | 4.5 | 1.1 | 0.75 | 33/97 | Q2 | 66.49 | 0.002 | 0.389 | 1.320 | Q2 | 26 | 0.0% | 7.3 | 6.9 | 0 | 12.1% | 2025-04-21 10:01:02 | 바로가기 |
| VISUAL COMPUTER | SPRINGER | 0178-2789 | 1432-2315 | SCIE | COMPUTER SCIENCE, SOFTWARE ENGINEERING | 4,726 | 3.5 | Q2 | 31.0 | 69.0 | 34/108 | 2.9 | Q2 | 2.4 | 0.6 | 0.88 | 36/132 | Q2 | 73.11 | 0.004 | 0.800 | 0.411 | Q3 | 403 | 99.3% | 2.9 | 5.2 | 400 | 8.2% | 2025-04-21 09:42:31 | 바로가기 |
| ACCOUNTING REVIEW | AMER ACCOUNTING ASSOC | 0001-4826 | 1558-7967 | SSCI | BUSINESS, FINANCE | 18,840 | 4.1 | Q2 | 31.1 | 68.9 | 35/111 | 6.6 | Q1 | 4.0 | 2.1 | 1.47 | 21/230 | Q1 | 91.09 | 0.013 | 2.913 | 3.454 | Q1 | 85 | 98.8% | 12.3 | 12.3 | 84 | 0.0% | 2025-04-21 09:35:07 | 바로가기 |
| AMERICAN HEART JOURNAL | MOSBY-ELSEVIER | 0002-8703 | 1097-6744 | SCIE | CARDIAC & CARDIOVASCULAR SYSTEMS | 20,472 | 4.8 | Q2 | 31.1 | 68.9 | 45/143 | 4.4 | Q2 | 4.7 | 1.1 | 1.19 | 43/215 | Q1 | 80.23 | 0.018 | 3.867 | 2.010 | Q1 | 178 | 93.8% | 13.2 | 6.6 | 167 | 21.4% | 2025-04-21 09:36:14 | 바로가기 |
| AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | AMER PHYSIOLOGICAL SOC | 0363-6135 | 1522-1539 | SCIE | CARDIAC & CARDIOVASCULAR SYSTEMS | 29,226 | 4.8 | Q2 | 31.1 | 68.9 | 45/143 | 5.0 | Q2 | 4.3 | 1.5 | 1.21 | 42/215 | Q1 | 80.70 | 0.013 | 2.826 | 1.146 | Q2 | 196 | 83.7% | 12.7 | 8.6 | 164 | 5.2% | 2025-04-21 09:36:13 | 바로가기 |
| AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | AMER PHYSIOLOGICAL SOC | 1040-0605 | 1522-1504 | SCIE | RESPIRATORY SYSTEM | 15,532 | 4.9 | Q2 | 31.1 | 68.9 | 21/66 | 5.0 | Q2 | 4.7 | 1.1 | 1.35 | 13/101 | Q1 | 87.62 | 0.010 | 2.264 | 1.292 | Q2 | 128 | 89.8% | 9.8 | 8.4 | 115 | 6.8% | 2025-04-21 10:35:03 | 바로가기 |
| ASN Neuro | SAGE PUBLICATIONS LTD | 1759-0914 | 1759-0914 | SCIE | NEUROSCIENCES | 1,373 | 4.7 | Q2 | 31.1 | 68.9 | 85/272 | 4.6 | Q2 | 4.5 | 0.9 | 0.79 | 153/306 | Q2 | 50.16 | 0.001 | 0.229 | 0.902 | Q3 | 35 | 68.6% | 6.8 | 8.5 | 24 | 94.5% | 2025-04-21 10:19:15 | 바로가기 |
| CLINICAL NEUROPHYSIOLOGY | ELSEVIER IRELAND LTD | 1388-2457 | 1872-8952 | SCIE | NEUROSCIENCES | 23,134 | 4.7 | Q2 | 31.1 | 68.9 | 85/272 | 4.5 | Q2 | 4.4 | 1.2 | 1.04 | 87/306 | Q2 | 71.73 | 0.015 | 3.254 | 1.268 | Q2 | 200 | 89.5% | 11.1 | 9.6 | 179 | 28.0% | 2025-04-21 10:18:47 | 바로가기 |
| Developmental Cognitive Neuroscience | ELSEVIER SCI LTD | 1878-9293 | 1878-9307 | SCIE | NEUROSCIENCES | 6,014 | 4.7 | Q2 | 31.1 | 68.9 | 85/272 | 6.9 | Q1 | 4.2 | 1.0 | 1.35 | 43/306 | Q1 | 86.11 | 0.013 | 2.735 | 2.591 | Q1 | 121 | 97.5% | 4.7 | 8.6 | 118 | 97.2% | 2025-04-21 10:19:01 | 바로가기 |
| Environmental Toxicology and Pharmacology | ELSEVIER | 1382-6689 | 1872-7077 | SCIE | PHARMACOLOGY & PHARMACY | 10,445 | 4.3 | Q2 | 31.1 | 68.9 | 87/278 | 4.8 | Q2 | 4.1 | 1.1 | 1.22 | 52/366 | Q1 | 85.93 | 0.006 | 1.259 | 0.712 | Q2 | 194 | 92.8% | 6.5 | 7.4 | 180 | 7.4% | 2025-04-21 10:24:13 | 바로가기 |
| Expert Opinion on Drug Metabolism & Toxicology | TAYLOR & FRANCIS LTD | 1742-5255 | 1744-7607 | SCIE | PHARMACOLOGY & PHARMACY | 5,089 | 4.3 | Q2 | 31.1 | 68.9 | 87/278 | 4.2 | Q2 | 4.2 | 0.9 | 0.59 | 202/366 | Q3 | 44.95 | 0.004 | 0.817 | 0.892 | Q2 | 62 | 12.9% | 7.3 | 7.6 | 8 | 11.0% | 2025-04-21 10:24:20 | 바로가기 |
페이지 이동: